Santos M, Rappa G, Karbanova J, Diana P, Cirrincione G, Carbone D
Nat Commun. 2023; 14(1):4588.
PMID: 37563144
PMC: 10415338.
DOI: 10.1038/s41467-023-40227-8.
Robert M, Lytvyn V, Deforet F, Gilbert R, Gaillet B
Mol Biotechnol. 2016; 59(1):9-23.
PMID: 27830536
DOI: 10.1007/s12033-016-9987-1.
Bender R, Muth A, Schneider I, Friedel T, Hartmann J, Pluckthun A
PLoS Pathog. 2016; 12(6):e1005641.
PMID: 27281338
PMC: 4900575.
DOI: 10.1371/journal.ppat.1005641.
Sugden S, Bego M, Pham T, Cohen E
Viruses. 2016; 8(3):67.
PMID: 26950141
PMC: 4810257.
DOI: 10.3390/v8030067.
Fackler O
Viruses. 2015; 7(12):6730-8.
PMID: 26703715
PMC: 4690893.
DOI: 10.3390/v7122970.
HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation.
Rosa A, Chande A, Ziglio S, De Sanctis V, Bertorelli R, Goh S
Nature. 2015; 526(7572):212-7.
PMID: 26416734
PMC: 4861059.
DOI: 10.1038/nature15399.
SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef.
Usami Y, Wu Y, Gottlinger H
Nature. 2015; 526(7572):218-23.
PMID: 26416733
PMC: 4600458.
DOI: 10.1038/nature15400.
The activity of Nef on HIV-1 infectivity.
Basmaciogullari S, Pizzato M
Front Microbiol. 2014; 5:232.
PMID: 24904546
PMC: 4033043.
DOI: 10.3389/fmicb.2014.00232.
The Nef-like effect of murine leukemia virus glycosylated gag on HIV-1 infectivity is mediated by its cytoplasmic domain and depends on the AP-2 adaptor complex.
Usami Y, Popov S, Gottlinger H
J Virol. 2014; 88(6):3443-54.
PMID: 24403584
PMC: 3957955.
DOI: 10.1128/JVI.01933-13.
HIV-1 Nef responsiveness is determined by Env variable regions involved in trimer association and correlates with neutralization sensitivity.
Usami Y, Gottlinger H
Cell Rep. 2013; 5(3):802-12.
PMID: 24209751
PMC: 3864691.
DOI: 10.1016/j.celrep.2013.09.028.
HIV-1 infection is blocked at an early stage in cells devoid of mitochondrial DNA.
Lu G, Matsuura S, Barrientos A, Scott W
PLoS One. 2013; 8(10):e78035.
PMID: 24205077
PMC: 3804459.
DOI: 10.1371/journal.pone.0078035.
Viral attachment induces rapid recruitment of an innate immune sensor (TRIM5α) to the plasma membrane.
Ohmine S, Singh R, Marks D, Meyer M, Pagano R, Ikeda Y
J Innate Immun. 2013; 5(4):414-24.
PMID: 23548691
PMC: 3758239.
DOI: 10.1159/000346963.
The trinity of the cortical actin in the initiation of HIV-1 infection.
Spear M, Guo J, Wu Y
Retrovirology. 2012; 9:45.
PMID: 22640593
PMC: 3416652.
DOI: 10.1186/1742-4690-9-45.
The Nef-infectivity enigma: mechanisms of enhanced lentiviral infection.
Vermeire J, Vanbillemont G, Witkowski W, Verhasselt B
Curr HIV Res. 2011; 9(7):474-89.
PMID: 22103831
PMC: 3355465.
DOI: 10.2174/157016211798842099.
CD4 and MHC class 1 down-modulation activities of nef alleles from brain- and lymphoid tissue-derived primary HIV-1 isolates.
Gray L, Gabuzda D, Cowley D, Ellett A, Chiavaroli L, Wesselingh S
J Neurovirol. 2010; 17(1):82-91.
PMID: 21165790
PMC: 4395859.
DOI: 10.1007/s13365-010-0001-6.
The HIV envelope but not VSV glycoprotein is capable of mediating HIV latent infection of resting CD4 T cells.
Yu D, Wang W, Yoder A, Spear M, Wu Y
PLoS Pathog. 2009; 5(10):e1000633.
PMID: 19851458
PMC: 2760144.
DOI: 10.1371/journal.ppat.1000633.
Measurement of human immunodeficiency virus type 1 preintegration transcription by using Rev-dependent Rev-CEM cells reveals a sizable transcribing DNA population comparable to that from proviral templates.
Iyer S, Yu D, Biancotto A, Margolis L, Wu Y
J Virol. 2009; 83(17):8662-73.
PMID: 19553325
PMC: 2738211.
DOI: 10.1128/JVI.00874-09.
TLR2 and TLR4 triggering exerts contrasting effects with regard to HIV-1 infection of human dendritic cells and subsequent virus transfer to CD4+ T cells.
Thibault S, Fromentin R, Tardif M, Tremblay M
Retrovirology. 2009; 6:42.
PMID: 19419540
PMC: 2691729.
DOI: 10.1186/1742-4690-6-42.
Human immunodeficiency virus type 1 Nef incorporation into virions does not increase infectivity.
Laguette N, Benichou S, Basmaciogullari S
J Virol. 2008; 83(2):1093-104.
PMID: 18987145
PMC: 2612363.
DOI: 10.1128/JVI.01633-08.
Nef can enhance the infectivity of receptor-pseudotyped human immunodeficiency virus type 1 particles.
Pizzato M, Popova E, Gottlinger H
J Virol. 2008; 82(21):10811-9.
PMID: 18715908
PMC: 2573167.
DOI: 10.1128/JVI.01150-08.